Logo image of XY6.DE

XYLEM INC (XY6.DE) Stock Fundamental Analysis

Europe - FRA:XY6 - US98419M1009 - Common Stock

124.55 EUR
+0.6 (+0.48%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

5

Overall XY6 gets a fundamental rating of 5 out of 10. We evaluated XY6 against 105 industry peers in the Machinery industry. Both the profitability and the financial health of XY6 get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, XY6 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

XY6 had positive earnings in the past year.
In the past year XY6 had a positive cash flow from operations.
Each year in the past 5 years XY6 has been profitable.
XY6 had a positive operating cash flow in each of the past 5 years.
XY6.DE Yearly Net Income VS EBIT VS OCF VS FCFXY6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of XY6 (5.46%) is better than 74.76% of its industry peers.
XY6 has a Return On Equity (8.47%) which is comparable to the rest of the industry.
XY6 has a Return On Invested Capital (5.48%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for XY6 is below the industry average of 8.53%.
Industry RankSector Rank
ROA 5.46%
ROE 8.47%
ROIC 5.48%
ROA(3y)4.55%
ROA(5y)4.34%
ROE(3y)8.17%
ROE(5y)9.27%
ROIC(3y)5.5%
ROIC(5y)5.55%
XY6.DE Yearly ROA, ROE, ROICXY6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of XY6 (10.74%) is better than 86.41% of its industry peers.
In the last couple of years the Profit Margin of XY6 has grown nicely.
XY6 has a better Operating Margin (13.28%) than 85.44% of its industry peers.
In the last couple of years the Operating Margin of XY6 has remained more or less at the same level.
Looking at the Gross Margin, with a value of 37.81%, XY6 is in line with its industry, outperforming 45.63% of the companies in the same industry.
XY6's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.28%
PM (TTM) 10.74%
GM 37.81%
OM growth 3Y3.16%
OM growth 5Y-1.19%
PM growth 3Y8.14%
PM growth 5Y6.35%
GM growth 3Y-0.44%
GM growth 5Y-0.76%
XY6.DE Yearly Profit, Operating, Gross MarginsXY6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XY6 is destroying value.
Compared to 1 year ago, XY6 has more shares outstanding
XY6 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, XY6 has an improved debt to assets ratio.
XY6.DE Yearly Shares OutstandingXY6.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
XY6.DE Yearly Total Debt VS Total AssetsXY6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 4.62 indicates that XY6 is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.62, XY6 belongs to the top of the industry, outperforming 88.35% of the companies in the same industry.
XY6 has a debt to FCF ratio of 2.36. This is a good value and a sign of high solvency as XY6 would need 2.36 years to pay back of all of its debts.
The Debt to FCF ratio of XY6 (2.36) is better than 75.73% of its industry peers.
XY6 has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
XY6 has a better Debt to Equity ratio (0.17) than 69.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.36
Altman-Z 4.62
ROIC/WACC0.6
WACC9.18%
XY6.DE Yearly LT Debt VS Equity VS FCFXY6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

XY6 has a Current Ratio of 1.90. This is a normal value and indicates that XY6 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of XY6 (1.90) is better than 66.99% of its industry peers.
A Quick Ratio of 1.43 indicates that XY6 should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.43, XY6 belongs to the best of the industry, outperforming 81.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.43
XY6.DE Yearly Current Assets VS Current LiabilitesXY6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

5

3. Growth

3.1 Past

XY6 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.37%, which is quite good.
Measured over the past 5 years, XY6 shows a small growth in Earnings Per Share. The EPS has been growing by 7.22% on average per year.
The Revenue has been growing slightly by 3.98% in the past year.
The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)15.37%
EPS 3Y19.95%
EPS 5Y7.22%
EPS Q2Q%15.6%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y18.12%
Revenue growth 5Y10.28%
Sales Q2Q%6.09%

3.2 Future

Based on estimates for the next years, XY6 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.56% on average per year.
The Revenue is expected to grow by 5.56% on average over the next years.
EPS Next Y14%
EPS Next 2Y12.78%
EPS Next 3Y12.06%
EPS Next 5Y10.56%
Revenue Next Year5.42%
Revenue Next 2Y5.33%
Revenue Next 3Y5.3%
Revenue Next 5Y5.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XY6.DE Yearly Revenue VS EstimatesXY6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
XY6.DE Yearly EPS VS EstimatesXY6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.77, XY6 can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as XY6.
XY6's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.42.
Based on the Price/Forward Earnings ratio of 26.73, the valuation of XY6 can be described as expensive.
XY6's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. XY6 is more expensive than 69.90% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.94. XY6 is around the same levels.
Industry RankSector Rank
PE 31.77
Fwd PE 26.73
XY6.DE Price Earnings VS Forward Price EarningsXY6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

74.76% of the companies in the same industry are cheaper than XY6, based on the Enterprise Value to EBITDA ratio.
XY6's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. XY6 is more expensive than 66.99% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.96
EV/EBITDA 20.92
XY6.DE Per share dataXY6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
XY6 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as XY6's earnings are expected to grow with 12.06% in the coming years.
PEG (NY)2.27
PEG (5Y)4.4
EPS Next 2Y12.78%
EPS Next 3Y12.06%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.07%, XY6 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.47, XY6 has a dividend in line with its industry peers.
With a Dividend Yield of 1.07, XY6 pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.07%

5.2 History

On average, the dividend of XY6 grows each year by 8.36%, which is quite nice.
Dividend Growth(5Y)8.36%
Div Incr Years4
Div Non Decr Years4
XY6.DE Yearly Dividends per shareXY6.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

XY6 pays out 39.55% of its income as dividend. This is a sustainable payout ratio.
XY6's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP39.55%
EPS Next 2Y12.78%
EPS Next 3Y12.06%
XY6.DE Yearly Income VS Free CF VS DividendXY6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
XY6.DE Dividend Payout.XY6.DE Dividend Payout, showing the Payout Ratio.XY6.DE Dividend Payout.PayoutRetained Earnings

XYLEM INC

FRA:XY6 (10/17/2025, 7:00:00 PM)

124.55

+0.6 (+0.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners95.11%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap30.32B
Analysts79.26
Price Target137.8 (10.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.07%
Yearly Dividend1.24
Dividend Growth(5Y)8.36%
DP39.55%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)6.98%
Max EPS beat(2)7.92%
EPS beat(4)3
Avg EPS beat(4)4.43%
Min EPS beat(4)-0.98%
Max EPS beat(4)7.92%
EPS beat(8)7
Avg EPS beat(8)4.96%
EPS beat(12)11
Avg EPS beat(12)9.17%
EPS beat(16)15
Avg EPS beat(16)9.46%
Revenue beat(2)2
Avg Revenue beat(2)1.67%
Min Revenue beat(2)0.44%
Max Revenue beat(2)2.91%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-4.15%
Max Revenue beat(4)2.91%
Revenue beat(8)7
Avg Revenue beat(8)0.99%
Revenue beat(12)11
Avg Revenue beat(12)2.11%
Revenue beat(16)13
Avg Revenue beat(16)1.71%
PT rev (1m)0.32%
PT rev (3m)9.78%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)3.9%
EPS NY rev (1m)0.28%
EPS NY rev (3m)4.33%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)2.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.24%
Valuation
Industry RankSector Rank
PE 31.77
Fwd PE 26.73
P/S 4.06
P/FCF 41.96
P/OCF 28.93
P/B 3.2
P/tB 73.32
EV/EBITDA 20.92
EPS(TTM)3.92
EY3.15%
EPS(NY)4.66
Fwd EY3.74%
FCF(TTM)2.97
FCFY2.38%
OCF(TTM)4.3
OCFY3.46%
SpS30.7
BVpS38.95
TBVpS1.7
PEG (NY)2.27
PEG (5Y)4.4
Profitability
Industry RankSector Rank
ROA 5.46%
ROE 8.47%
ROCE 7.78%
ROIC 5.48%
ROICexc 5.95%
ROICexgc 26.08%
OM 13.28%
PM (TTM) 10.74%
GM 37.81%
FCFM 9.67%
ROA(3y)4.55%
ROA(5y)4.34%
ROE(3y)8.17%
ROE(5y)9.27%
ROIC(3y)5.5%
ROIC(5y)5.55%
ROICexc(3y)6.18%
ROICexc(5y)6.64%
ROICexgc(3y)24.67%
ROICexgc(5y)26.87%
ROCE(3y)7.81%
ROCE(5y)7.88%
ROICexcg growth 3Y5.31%
ROICexcg growth 5Y-3.31%
ROICexc growth 3Y-8.41%
ROICexc growth 5Y-8.35%
OM growth 3Y3.16%
OM growth 5Y-1.19%
PM growth 3Y8.14%
PM growth 5Y6.35%
GM growth 3Y-0.44%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.36
Debt/EBITDA 1.11
Cap/Depr 66.32%
Cap/Sales 4.35%
Interest Coverage 18.4
Cash Conversion 70.67%
Profit Quality 89.98%
Current Ratio 1.9
Quick Ratio 1.43
Altman-Z 4.62
F-Score8
WACC9.18%
ROIC/WACC0.6
Cap/Depr(3y)69.14%
Cap/Depr(5y)73.04%
Cap/Sales(3y)3.73%
Cap/Sales(5y)3.79%
Profit Quality(3y)102.28%
Profit Quality(5y)127.3%
High Growth Momentum
Growth
EPS 1Y (TTM)15.37%
EPS 3Y19.95%
EPS 5Y7.22%
EPS Q2Q%15.6%
EPS Next Y14%
EPS Next 2Y12.78%
EPS Next 3Y12.06%
EPS Next 5Y10.56%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y18.12%
Revenue growth 5Y10.28%
Sales Q2Q%6.09%
Revenue Next Year5.42%
Revenue Next 2Y5.33%
Revenue Next 3Y5.3%
Revenue Next 5Y5.56%
EBIT growth 1Y23.43%
EBIT growth 3Y21.85%
EBIT growth 5Y8.97%
EBIT Next Year45.14%
EBIT Next 3Y19.79%
EBIT Next 5Y15.05%
FCF growth 1Y136.42%
FCF growth 3Y41.3%
FCF growth 5Y8.72%
OCF growth 1Y113.61%
OCF growth 3Y32.52%
OCF growth 5Y8.33%